UOC TRANSLATIONAL ONCOLOGY RESEARCH
Head: Giovanni Blandino, MD, PhD
STAFF
- Biroccio Annamaria
- Giacomini Patrizio
- Rizzo Maria
- Segatto Oreste
- Allegretti Matteo
- Anastasi Sergio
- Ascenzi Francesca
- Auciello Francesca Romana
- Benedetti Anna
- Bossi Gianluca
- Canu Valeria
- Covino Daniela Angela
- Cristinziano Giulia
- De Pascale Valentina
- Diaz Mendez Ana Belen
- Di Vito Serena
- Dinami Roberto
- Donzelli Sara
- Fontemaggi Giulia
- Ganci Federica
- Giordani Elena
- Iachettini Sara
- Lamberti Dante
- Lo Sardo Federica
- Matteoni Silvia
- Petti Eleonora
- Piastra Valentina
- Pompili Luca
- Porru Manuela
- Pulito Claudio
- Regazzo Giulia
- Ricciardi Elena
- Rizzo Angela
- Scafetta Giorgia
- Tremante Elisa
- Turco Chiara
- Valenti Fabio
- Ziccheddu Giovanna
- Zizza Pasquale
- D'Angelo Carmen
- Fraioli Rocco
- Maresca Carmen
- Varmi Marco
- Bernardi Roberto
- Americi Giorgia
- Brandi Renata
- Bouzidi Amani
- Carachino Alice
- Di Giuliani Marta
- Frascolla Carlotta
- Rutigliano Daniela
- Vaccarella Sebastiano
- Vari Giulia
The research objectives of the Translational Oncology Research Unit are pursed through the integrated experimental work of the following groups:
PI Blandino
- Allegretti Matteo
- Ascenzi Francesca
- Auciello Francesca Romana
- Benedetti Anna
- Bernardi Roberto
- Bossi Gianluca
- Brandi Renata
- Canu Valeria
- Covino Daniela Angela
- De Pascale Valentina
- Donzelli Sara
- Fontemaggi Giulia
- Frascolla Carlotta
- Ganci Federica
- Lo Sardo Federica
- Matteoni Silvia
- Piastra Valentina
- Pulito Claudio
- Rutigliano Daniela
- Scafetta Giorgia
- Turco Chiara
- Vaccarella Sebastiano
- Varmi Marco
Blandino’s group is actively pursuing the identification of molecular biomarkers non-coding RNAs whose association with the TP53 status may predict recurrence of head and neck cancers.
PI Biroccio
- Carachino Alice
- D'Angelo Carmen
- Di Vito Serena
- Dinami Roberto
- Iachettini Sara
- Maresca Carmen
- Petti Eleonora
- Porru Manuela
- Rizzo Angela
- Zizza Pasquale
Biroccio’s group is actively investigating the extra-telomeric role of TRF2 in oncogenesis with the aim to identify novel therapeutic targets for antitumoral therapies in colon cancer.
PI Giacomini
- Fraioli Rocco
- Giordani Elena
- Ricciardi Elena
- Valenti Fabio
- Ziccheddu Giovanna
Giacomini’s group is actively developing and optimizing nanoparticles for cancer therapeutics, and assays to detect circulating tumor DNA ctDNA in real-life Liquid Biopsy LBstudies.
PI Rizzo
- Di Giuliani Marta
- Diaz Mendez Ana Belen
- Regazzo Giulia
- Tremante Elisa
- Vari Giulia
Rizzo’s group is actively investigating the role of extracellular circulating miRNAs in hematopoietic malignancies and brain tumors as promising biomarkers for disease classification and outcome prediction.
PI Segatto
- Americi Giorgia
- Bouzidi Amani
- Anastasi Sergio
- Cristinziano Giulia
- Lamberti Dante
- Pompili Luca
The Segatto’s group has generated genetically defined mouse models of intrahepatic cholangiocarcinoma iCCA driven by FGFR2 fusion proteins FFP.These models are being used to identify iCCA vulnerabilities associated to oncogenic dependence from FFPs.